Mölnlycke Health Care AB
Clinical trials sponsored by Mölnlycke Health Care AB, explained in plain language.
A medical device company specializing in wound care and surgical products.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Can a special foam dressing speed up wound healing? Results expected Jun 2027 (estimated)
-
New bandage tested for leg ulcer healing
Disease control Not yet recruitingThis study compares two types of compression bandages for treating venous leg ulcers, which are slow-healing wounds on the lower leg. About 386 adults will receive either the new Mepi Press 2 or the standard UrgoK2 bandage for up to 12 weeks. The goal is to see if the new bandage…
Sponsor: Molnlycke Health Care AB • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Can a special foam dressing speed up wound healing?
Symptom relief Not yet recruitingThis trial is testing a soft silicone foam dressing called Mepilex Up on adults with leg or foot ulcers and skin tears. The goal is to see if the dressing helps wounds progress toward healing and is safe to use. About 70 participants will use the dressing for up to 6 weeks, and d…
Sponsor: Molnlycke Health Care AB • Aim: Symptom relief
Last updated Aug 28, 2026 00:00 UTC